Orphan drugs: Unmet societal need for non-profitable privately supplied new products

por Moors, Ellen H.M., Faber, Jan
Publicado 2007

Does market exclusivity hinder the development of Follow-on Orphan Medicinal Products in Europe?

por Brabers, Anne EM, Moors, Ellen HM, van Weely, Sonja, de Vrueh, Remco LA
Publicado 2011

Market Formation in a Global Health Transition

por de Haan, Freek, Moors, Ellen H.M., Dondorp, Arjen M., Boon, Wouter P.C.
Publicado 2021

Implementation of Magnetic Resonance Imaging-Guided Radiation Therapy in Routine Care: Opportunities and Challenges in the United States

por Hehakaya, Charisma, Sharma, Ankur M., van der Voort Van Zijp, Jochem R.N., Grobbee, Diederick E., Verkooijen, Helena M., Izaguirre, Enrique W., Moors, Ellen H.M.
Publicado 2022

Ethical, Regulatory and Market related aspects of Deploying Triple Artemisinin-Based Combination Therapies for Malaria treatment in Africa: A study protocol.

por Tindana, Paulina, de Haan, Freek, Mokuolu, Olugbenga Ayodeji, Guissou, Rosemonde, Bolarinwa, Oladimeji Akeem, Ouedraogo, Jean Bosco, Tou, Fatoumata, Boon, Wouter P.C, Moors, Ellen H.M, Dondorp, Arjen M, Dhorda, Mehul, Amaratunga, Chanaki, Cheah, Phaik Yeong
Publicado 2021